bpc 157 venous insufficiency Frontiers BPC-157: The Promise and Perils

Nature 546 , 118123 (2017)

In a dissenting comment, Sikiric and colleagues said that BPC-157 had been unjustly accused of potentially harmful effects. They pointed to a list of research findings that, in their view, rule out the possibility that the peptide causes cancer and other potential harms

Lumbar or sacral region

All biomarkers remained normal, and plasma levels returned to baseline within 24 hours

And that deficiency is largely due to years of low stomach acid levels due to our hypothyroidism, whether one is either undiagnosed due to the lousy TSH lab test or poorly treated on T4 meds

Regardless, the absence of reported side effects doesnt eliminate the need for caution